Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

RxSight, Inc. - Common Stock (NQ:RXST)

7.280 +0.630 (+9.47%)
Streaming Delayed Price Updated: 12:01 PM EDT, Aug 12, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 531,159
Open 6.750
Bid (Size) 7.280 (3)
Ask (Size) 7.300 (3)
Prev. Close 6.650
Today's Range 6.730 - 7.450
52wk Range 6.320 - 58.23
Shares Outstanding 33,981,877
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Bragar Eagel & Squire, P.C. Reminds Investors of Class Actions Against Neogen, Alto, RxSight, and Replimune and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Lost Money on RxSight, Inc. (RXST)? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Fraud Lawsuit

Performance

YTD
-78.9%
-78.9%
1 Month
-5.9%
-5.9%
3 Month
-47.1%
-47.1%
6 Month
-77.3%
-77.3%
1 Year
-86.0%
-86.0%

More News

Read More
SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against RxSight, Inc. (NASDAQ: RXST)
From Bernstein Liebhard LLP
Via GlobeNewswire
Earnings Scheduled For August 7, 2025
Via Benzinga
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in RxSight, Inc. of Class Action Lawsuit and Upcoming Deadlines - RXST
From Pomerantz LLP
Via GlobeNewswire
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages RxSight, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – RXST
From The Rosen Law Firm PA
Via GlobeNewswire
Class Action Filed Against RxSight, Inc. (RXST) Seeking Recovery for Investors - Contact Levi & Korsinsky
Via TheNewswire.com
Topics Fraud Lawsuit
Class Action Filed Against RxSight, Inc. (RXST) Seeking Recovery for Investors - Contact Levi & Korsinsky
Via NewMediaWire
Topics Fraud Lawsuit
RxSight (RXST) Q2 Loss Beats Estimates
Via The Motley Fool
RxSight, Inc. Reports Second Quarter 2025 Financial Results
From RxSight, Inc.
Via GlobeNewswire
Levi & Korsinsky Reminds RxSight, Inc. Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of September 22, 2025 - RXST
Via NewMediaWire
Topics Fraud Lawsuit
Levi & Korsinsky Reminds RxSight, Inc. Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of September 22, 2025 - RXST
Via TheNewswire.com
Topics Fraud Lawsuit
Shareholders That Lost Money on RxSight, Inc. (RXST) Should Contact Levi & Korsinsky About Pending Class Action - RXST
Via NewMediaWire
Topics Fraud Lawsuit
Shareholders That Lost Money on RxSight, Inc. (RXST) Should Contact Levi & Korsinsky About Pending Class Action - RXST
Via TheNewswire.com
Topics Fraud Lawsuit
Bragar Eagel & Squire, P.C. Reminds Investors of Class Actions Against Neogen, Alto, RxSight, and Replimune and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of RxSight
From Faruqi & Faruqi LLP
Via GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in RxSight, Inc. of Class Action Lawsuit and Upcoming Deadlines - RXST
From Pomerantz LLP
Via GlobeNewswire
Investors in RxSight, Inc. Should Contact Levi & Korsinsky Before September 22, 2025 to Discuss Your Rights - RXST
Via NewMediaWire
Topics Fraud Lawsuit
Investors in RxSight, Inc. Should Contact Levi & Korsinsky Before September 22, 2025 to Discuss Your Rights - RXST
Via TheNewswire.com
Topics Fraud Lawsuit
RxSight, Inc. Sued for Securities Law Violations - Contact Levi & Korsinsky Before September 22, 2025 to Discuss Your Rights - RXST
Via NewMediaWire
Topics Fraud Lawsuit
RxSight, Inc. Sued for Securities Law Violations - Contact Levi & Korsinsky Before September 22, 2025 to Discuss Your Rights - RXST
Via TheNewswire.com
Topics Fraud Lawsuit
RXSIGHT, INC. (NASDAQ: RXST) SHAREHOLDER ALERT Bernstein Liebhard LLP Reminds RxSight Inc. Investors of Upcoming Deadline
From Bernstein Liebhard LLP
Via GlobeNewswire
RxSight, Inc. Appoints Raymond W. Cohen to Its Board of Directors
From RxSight, Inc.
Via GlobeNewswire
Bragar Eagel & Squire, P.C. Is Reminds Investors of Class Actions Against Neogen, Alto, RxSight, and Replimune and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
RxSight, Inc. Sued for Securities Law Violations - Contact Levi & Korsinsky Before September 22, 2025 to Discuss Your Rights - RXST
Via NewMediaWire
Topics Fraud Lawsuit

Frequently Asked Questions

Is RxSight, Inc. - Common Stock publicly traded?
Yes, RxSight, Inc. - Common Stock is publicly traded.
What exchange does RxSight, Inc. - Common Stock trade on?
RxSight, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for RxSight, Inc. - Common Stock?
The ticker symbol for RxSight, Inc. - Common Stock is RXST on the Nasdaq Stock Market
What is the current price of RxSight, Inc. - Common Stock?
The current price of RxSight, Inc. - Common Stock is 7.280
When was RxSight, Inc. - Common Stock last traded?
The last trade of RxSight, Inc. - Common Stock was at 08/12/25 12:01 PM ET
What is the market capitalization of RxSight, Inc. - Common Stock?
The market capitalization of RxSight, Inc. - Common Stock is 247.39M
How many shares of RxSight, Inc. - Common Stock are outstanding?
RxSight, Inc. - Common Stock has 247M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.